SLS and ATNM are heading into the AACR summit with fresh leukemia-focused data catalysts expected to refocus investor attention. ・Sellas will present preclinical AML data on SLS009, demonstrating ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the best healthcare penny stocks to buy according to hedge funds. On ...

The lights may be starting to go out for NASA’s Space Launch System program. On Wednesday, one of the Republican space policy leaders most consistently opposed to commercial heavy lift rockets over ...

NASA’s mega moon rocket will begin a slow trek to its Florida launchpad early Saturday, marking a major milestone for Artemis II, the agency’s first crewed lunar mission in over 50 years. The rollout ...

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. However, I believe their SLS009 candidate as a CDK9 inhibitor further gives the stock broad AML ...

Okay, space fans. The moment is almost here. NASA is about to launch its next-generation rocket for the first time and send it hurtling out beyond the Moon. It’s going to be a wild time, but honestly, ...

The acting associate administrator for human exploration and operations at NASA, Ken Bowersox, said that current schedules calling for a late 2020 first launch of SLS are "very, very aggressive" that ...

While NASA is developing a cargo version of the SLS that could be used for science missions, the limited supply chain and requirements of the Artemis program will limit its use to missions launching ...

In the fervor-filled days leading up to the November 16 launch of the long-awaited Artemis I mission, an uncrewed trip around the moon, some industry insiders admitted to having conflicting emotions ...

The White House seeks to cancel NASA's Gateway moon-orbiting space station and retire SLS and Orion after just two more flights. When you purchase through links on our site, we may earn an affiliate ...